Hummingbird Bioscience announces US$19m in Series B financing led by Mirae and GNTech

Hummingbird Biosciences, a Heritas Venture Fund-backed company, announced that it has received US$19 million in Series B funding. The financing was co-led by Mirae Asset Venture Investment and GNTech Venture Capital, joined by Delian Capital, Mirae Asset Capital, GiltEdge Partners, HB Investment, Wooshin Venture Investment, and Kiwoom Investment-Shinhan Capital. The...

Read more...

Hummingbird Bioscience closes extended Series A financing to advance clinical pipeline

Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capital Management and SEEDS Capital, the investment arm of Enterprise Singapore. Hummingbird’s existing investors,...

Read more...

CXA raises US$25m to accelerate expansion across Asia-Pacific

New investors HSBC, Singtel Innov8, Telkom Indonesia MDI Ventures, Sumitomo Corporation Equity Asia, Muang Thai Fuchsia Ventures, Humanica, Heritas Venture Fund and others join CXA’s latest financing round This strategic capital will accelerate CXA’s growth momentum in the Asia-Pacific region and reinforce the company’s mission of improving the health and...

Read more...

Alchemy FoodTech secures seven-digit investment first close in Pre-Series A financing

Alchemy FoodTech, a Singapore based food-­‐tech solution company specializing in the development of lower Glycemic Index (“GI”) carbohydrates to tackle diabetes, today announced the completion of its first close to their Pre-­‐Series A round led by Heritas Capital Management and co-­led by SEEDS Capital, the investment arm of Enterprise...

Read more...